Posted by Michael Wonder on 03 Jan 2017
Allergan and others raise medicine prices just under 10%, hoping to avoid public outcry
3 January 2017 - A new year often means new prices for pharmaceuticals, and several companies have imposed price hikes just shy of 10% on numerous medicines, a move that appears designed to avoid withering scrutiny of companies that take double-digit increases.
One notable example is Allergan, which last year attempted to single-handedly staunch criticism of the pharmaceutical industry by issuing a “social contract” in which it promised to avoid “price gouging” and limit price hikes to single-digit percentage increases.
